ANGLE PLC – a small British company changing the world in cancer

Episode 58 | 7 June 2022 | Length: 00:23:20

Andrew Newland

Andrew Newland

Andrew Newland founded ANGLE PLC (AIM:AGL) in 1994. Twenty-eight years on and his company has won FDA clearance for ANGLE’s liquid biopsy Parsortix initiative which in the U.S. alone has a $100 billion per annum addressable market.

“We’re solving an enormously challenging and important medical question,” says Newland who says the ultimate growth of Parsortix is unbounded.

<< Back to all episodes